Phibro Animal Health (PAHC) Q1 Earnings and Revenues Top Estimates

Core Insights - Phibro Animal Health (PAHC) reported quarterly earnings of $0.73 per share, exceeding the Zacks Consensus Estimate of $0.59 per share, and showing significant growth from $0.35 per share a year ago [1][2] - The company achieved revenues of $363.9 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.60% and increasing from $260.4 million year-over-year [3] - Phibro's stock has appreciated approximately 100.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 15.1% [4] Earnings Performance - The earnings surprise for the recent quarter was +23.73%, following a previous surprise of +9.62% when actual earnings were $0.57 compared to an expected $0.52 [2] - Over the last four quarters, Phibro has consistently surpassed consensus EPS estimates [2] Future Outlook - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and future earnings expectations [4] - Current consensus EPS estimate for the upcoming quarter is $0.62 on revenues of $357.21 million, and for the current fiscal year, it is $2.59 on revenues of $1.46 billion [8] - The estimate revisions trend for Phibro was favorable ahead of the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [7]